GENPHARMASEC's board has approved its 34th Annual General Meeting (AGM) for September 29, 2026, to be held virtually.

Key dates for e-voting (September 26-28, 2026) and book closure (September 23-29, 2026) were also set.

The board approved the Annual Report and Director's Report for the financial year 2025-26. Shareholders will vote on the re-appointment of Mr. Sohan Chaturvedi as Whole Time Director and a proposal to advance loans or give guarantees, subject to shareholder approval.

These approvals ensure ongoing corporate governance and strategic financial flexibility for the company.